Pharmaceutical Information |
Drug Name |
Testolactone |
Drug ID |
BADD_D02169 |
Description |
An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer. |
Indications and Usage |
For palliative treatment of advanced breast cancer in postmenopausal women. |
Marketing Status |
Discontinued |
ATC Code |
Not Available |
DrugBank ID |
DB00894
|
KEGG ID |
D00153
|
MeSH ID |
D013738
|
PubChem ID |
13769
|
TTD Drug ID |
D0C7JF
|
NDC Product Code |
Not Available |
Synonyms |
Testolactone | 1-Dehydrotestolactone | 1 Dehydrotestolactone | delta(1)-Testolactone | Teslac |
|
Chemical Information |
Molecular Formula |
C19H24O3 |
CAS Registry Number |
968-93-4 |
SMILES |
CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|